FDA approves new painkiller that shows promise and challenges of opioid alternatives
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries.
FDA Approves the First Non-Opioid Pain Medicine in 20 Years
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and represent the first new class of pain medications in 20 years—and the first non ...
Psychology Today3h
Opioid Crisis: Grading the Progress of National Initiatives
Drug experts Drs. Volkow and McLellan set out a road map to reverse the opioid epidemic in 2016. Find out how we're doing now ...
FDA approves new type of nonopioid painkiller for acute pain
The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC ...
What Is Journavx? First Pain Medication Approved by FDA in Over Two Decades
This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.
FDA approves Vertex's non-opioid painkiller, first new kind of pain medicine in decades
The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive ...
Extending 'Dry January' could have lasting benefits
"Dry January" is a social movement encouraging sobriety for the month. More people, especially younger adults, are choosing ...
RFK Jr.'s drug policy under Trump could worsen the overdose crisis, experts warn
Trump prioritizes criminalization over public health in fighting the overdose crisis. Experts say that doesn't work ...
Matthew Perry Foundation and Massachusetts General Hospital Officially Launch Fellowship in Addiction Medicine
The Matthew Perry Foundation Fellowship in Addiction Medicine - the first official program to bear the late actor's name outside of the nonprofit - has selected Dr. Sarah "SK Kler for its inaugural ...